![]() |
Volumn 86, Issue 6, 2001, Pages 1588-1589
|
Modification of von Willebrand disease after liver transplantation
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD CLOTTING FACTOR 8;
BLOOD CLOTTING FACTOR 8 CONCENTRATE;
DESMOPRESSIN;
POLYMER;
PREDNISONE;
RISTOCETIN;
TACROLIMUS;
TRANEXAMIC ACID;
VON WILLEBRAND FACTOR;
ADULT;
ANAMNESIS;
BLEEDING TENDENCY;
BLEEDING TIME;
CANCER RECURRENCE;
CASE REPORT;
CLINICAL FEATURE;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG WITHDRAWAL;
ELECTROIMMUNOASSAY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
EPISTAXIS;
EXON;
FEMALE;
FOLLOW UP;
GENETIC DISORDER;
GRAFT REJECTION;
HALF LIFE TIME;
HEMOSTASIS;
HETEROZYGOSITY;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LABORATORY DIAGNOSIS;
LETTER;
LIVER CANCER;
LIVER TRANSPLANTATION;
MOLECULAR WEIGHT;
NONSENSE MUTATION;
POSTOPERATIVE HEMORRHAGE;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
PROPHYLAXIS;
PROTEIN ANALYSIS;
PROTEIN BLOOD LEVEL;
PROTEIN MODIFICATION;
TREATMENT OUTCOME;
VON WILLEBRAND DISEASE;
|
EID: 0035655543
PISSN: 03406245
EISSN: None
Source Type: Journal
DOI: 10.1055/s-0037-1616772 Document Type: Letter |
Times cited : (5)
|
References (8)
|